Judy del Mundo, MD
Allergy & Immunology · San Jose, CANPI 1942203013
Payments from drug & device makers
Across 184 payments — averaging $28.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Sanofi$238
- Pfizer$236
- Teva Pharmaceuticals USA, Inc.$225
- Regeneron Healthcare Solutions, Inc.$187
- plus $1K from 21 others
What the payments were for
- Food & beverage$5,19899%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 67 | $2,011 |
| GSK | 47 | $1,235 |
| Sanofi | 8 | $238 |
| Pfizer | 6 | $236 |
| Teva Pharmaceuticals USA, Inc. | 9 | $225 |
| Regeneron Healthcare Solutions, Inc. | 6 | $187 |
| Alk-abello, Inc | 4 | $178 |
| Greer Laboratories, Inc. | 4 | $122 |
| Galderma Laboratories, L.p. | 3 | $79 |
| Kaleo, Inc. | 4 | $78 |
| Novartis | 4 | $71 |
| Covis Pharma GmbH | 1 | $60 |
| Grifols USA, LLC | 3 | $59 |
| CSL Behring | 2 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Optinose US, Inc. | 2 | $43 |
| Amgen | 1 | $33 |
| Lilly USA, LLC | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| Organon | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Octapharma USA, Inc. | 1 | $24 |
| Circassia Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,233 in reported general payments places this provider in the 60th percentile of 426 allergy & immunology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $40,703 |
| Spiriva RespimatTiotropium Bromide | 20 | $12,395 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $8,914 |
| Arnuity ElliptaFluticasone Furoate | 29 | $6,676 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $6,457 |
| Wixela InhubFluticasone Propion/Salmeterol | 43 | $5,974 |
| BreynaBudesonide/Formoterol Fumarate | 30 | $5,820 |
| Qvar RedihalerBeclomethasone Dipropionate | 15 | $5,556 |
| AlvescoCiclesonide | 13 | $3,487 |
| Fluticasone Propionate HfaFluticasone Propionate | 13 | $2,391 |
| Fluticasone Propionate | 108 | $1,943 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,856 |
| Montelukast Sodium | 140 | $1,765 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $1,680 |
| Azelastine Hcl | 53 | $1,667 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Arnuity Ellipta | $1,235 | $47,37994 claims |
| AstraZenecaSymbicort | $2,011 | $8,91430 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $225 | $5,55615 claims |
| Covis Pharma GmbHAlvesco | $60 | $3,48713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 426 allergy & immunology providers in California.
Other allergy & immunology in San Jose
- Alan GoldsobelSan Jose$3.3M
- James WolfeSan Jose$2.5M
- Robert TorranoSan Jose$57K
- Kenneth KimLong Beach$18.5M
- Purvi MehraSan Diego$6.3M
- Bob GengSan Diego$6M
- Alexander GreinerSan Diego$4.8M
- Tonny TanusBakersfield$4.5M
- Raffi TachdjianSanta Monica$4.2M
- Vinay MehtaLaguna Niguel$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.